Neumora Therapeutics (NMRA) Interest Coverage Ratio (2025 - 2026)

Neumora Therapeutics (NMRA) recorded quarterly Interest Coverage Ratio of 28.51 in Q1 2026, up 0.73% quarter-over-quarter from 28.72 in Q4 2025.

Neumora Therapeutics (NMRA) Interest Coverage Ratio (2025 - 2026) Analysis & Trends

Neumora Therapeutics' Interest Coverage Ratio history runs 2 years deep, the most recent figure standing at 28.51 for Q1 2026.

In Q1 2026, Interest Coverage Ratio changed N/A year-over-year to 28.51; the TTM figure through Mar 2026 stood at 48.11 (changed N/A YoY), while the FY2025 annual figure was 74.92, changed N/A from the prior year.
Interest Coverage Ratio was 28.51 for Q1 2026 at Neumora Therapeutics, up from 28.72 in the prior quarter.
In the past five years, Interest Coverage Ratio ranged from a high of 28.51 in Q1 2026 to a low of 77.24 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	3.58
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-258.33
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	11.50
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	547.67
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	-
9	Abivax	90.15 Bn	90.15 Bn	-	11.79
10	Neumora Therapeutics	320.17 Mn	320.17 Mn	-	-28.51

Download Data